These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 219723)

  • 1. Clinical and laboratory features and treatment of visceral leishmaniasis in hospitalized patients in Northwestern Ethiopia.
    Maru M
    Am J Trop Med Hyg; 1979 Jan; 28(1):15-8. PubMed ID: 219723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral leishmaniasis (kala-azar) as a cause of fever of unknown origin.
    Geraci JE; Wilson WR; Thompson JH
    Mayo Clin Proc; 1980 Jul; 55(7):455-8. PubMed ID: 6247584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan.
    Veeken H; Ritmeijer K; Seaman J; Davidson R
    Trop Med Int Health; 2000 May; 5(5):312-7. PubMed ID: 10886792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)].
    Just G; Simader R; Helm EB; Stille W; Falk S; Stutte HJ; Hübner K
    Dtsch Med Wochenschr; 1988 Dec; 113(49):1920-2. PubMed ID: 2848675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post kala-azar ocular leishmaniasis.
    el Hassan AM; Khalil EA; el Sheikh EA; Zijlstra EE; Osman A; Ibrahim ME
    Trans R Soc Trop Med Hyg; 1998; 92(2):177-9. PubMed ID: 9764325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment.
    el Hassan AM; Ghalib HW; Zijlstra EE; Eltoum IA; Satti M; Ali MS; Ali HM
    Trans R Soc Trop Med Hyg; 1992; 86(3):245-8. PubMed ID: 1329273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An outbreak of acute kala-azar in a nomadic tribe in western Sudan: features of the disease in a previously non-immune population.
    Hashim FA; Ali MS; Satti M; el-Hassan AM; Ghalib HW; el Safi S; el Hag IA
    Trans R Soc Trop Med Hyg; 1994; 88(4):431-2. PubMed ID: 7570831
    [No Abstract]   [Full Text] [Related]  

  • 11. Deaths in visceral leishmaniasis (Kala-azar) during treatment.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Azad KA
    Med J Malaysia; 1996 Mar; 51(1):29-32. PubMed ID: 10967976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kala-azar in a four-year-old child 18 months after brief exposure in Malta.
    Ornvold K; Carstensen H; Magnussen P; Nielsen MH; Pedersen FK
    Acta Paediatr Scand; 1989 Jul; 78(4):650-2. PubMed ID: 2551125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: management of those who do not respond.
    Khalil EA; el Hassan AM; Zijlstra EE; Hashim FA; Ibrahim ME; Ghalib HW; Ali MS
    Ann Trop Med Parasitol; 1998 Mar; 92(2):151-8. PubMed ID: 9625910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of kala-azar in the Sudan with sodium stibogluconate: a randomized trial of three dosage regimens.
    Zijlstra EE; Siddig Ali M; el-Hassan AM; Hofland HW; el-Toum I; Satti M; Ghalib HW
    Trans R Soc Trop Med Hyg; 1993; 87(3):307-9. PubMed ID: 8236402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol in the treatment of visceral leishmaniasis.
    Kager PA; Rees PH; Wellde BT; Hockmeyer WT; Lyerly WH
    Trans R Soc Trop Med Hyg; 1981; 75(4):556-9. PubMed ID: 6275579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kala-azar: experience from a non-endemic area in India.
    Chandra J; Anand V; Patwari AK; Mandal RN; Aneja S; Sharma D
    J Trop Pediatr; 1995 Oct; 41(5):298-300. PubMed ID: 8531263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya.
    Mueller YK; Kolaczinski JH; Koech T; Lokwang P; Riongoita M; Velilla E; Brooker SJ; Chappuis F
    Am J Trop Med Hyg; 2014 Jan; 90(1):33-39. PubMed ID: 24218406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.
    Karki P; Koirala S; Parija SC; Hansdak SG; Das ML
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):154-8. PubMed ID: 9740292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.